Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer?

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 6, 2014, Pages 663-678

  Mason, Julie K ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Chemoprevention; Drug diet interaction; Flaxseed; Flaxseed oil; Lignan; linolenic acid

Indexed keywords

ANTINEOPLASTIC AGENT; LIGNAN; LINOLENIC ACID; PHYTOESTROGEN;

ANIMAL; BREAST NEOPLASMS; DIET THERAPY; DISEASE MODEL; DRUG INTERACTION; FEMALE; FLAX; HUMAN; RISK FACTOR;

ALPHA-LINOLENIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; FLAX; HUMANS; LIGNANS; PHYTOESTROGENS; RISK FACTORS;

EID: 84901494136     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2013-0420     Document Type: Review

References (125)

1. Aberg, U.W., Saarinen, N., Abrahamsson, A., Nurmi, T., Engblom, S., and Dabrosin, C. 2011. Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS One, 6(9): e25720. doi:10.1371/ journal.pone.0025720. PMID:21984941.
2. Abrahamsson, A., Morad, V., Saarinen, N.M., and Dabrosin, C. 2012. Estradiol, tamoxifen, and flaxseed alter IL-1beta and IL-1Ra levels in normal human breast tissue in vivo. J. Clin. Endocrinol. Metab. 97(11): E2044-E2054. doi:10. 1210/jc.2012-2288. PMID:22930784.
3. Adlercreutz, H. 2007. Lignans and human health. Crit. Rev. Clin. Lab. Sci. 44(5-6): 483-525. doi:10.1080/10408360701612942. PMID:17943494.
4. Adlercreutz, H., Bannwart, C., Wahala, K., Makela, T., Brunow, G., Hase, T., et al. 1993. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol. 44(2): 147-153. doi:10. 1016/0960-0760(93)90022-O. PMID:8382517.
5. American Cancer Society. 2013. Cancer Facts & Figures 2013. Atlanta, Ga., USA.
6. Anderson, B.M., and Ma, D.W. 2009. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 8: 33. doi:10.1186/1476-511X-8-33. PMID: 19664246.
7. Berger, J., and Moller, D.E. 2002. The mechanisms of action of PPARs. Annu. Rev. Med. 53: 409-435. doi:10.1146/annurev.med.53.082901.104018. PMID: 11818483.
8. Bergman Jungestrom, M., Thompson, L.U., and Dabrosin, C. 2007. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 13(3): 1061-1067. doi:10.1158/1078-0432.CCR-06-1651. PMID:17289903.
9. Birkved, F.K., Mortensen, A., Penalvo, J.L., Lindecrona, R.H., and Sorensen, I.K. 2011. Investigation into the cancer protective effect of flaxseed in Tg. NK (MMTV/c-neu) mice, a murine mammary tumor model. Genes Nutr. 6(4): 403-411. doi:10.1007/s12263-011-0214-1. PMID:21484161.
10. Boon, H.S., Olatunde, F., and Zick, S.M. 2007. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health, 7: 4. doi:10.1186/1472-6874-7-4. PMID: 17397542.
11. Boucher, B.A., Cotterchio, M., Curca, I.A., Kreiger, N., Harris, S.A., Kirsh, V.A., et al. 2012. Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada. Nutr. Cancer, 64(5): 695-703. doi:10.1080/01635581.2012.687426. PMID:22642930.
12. Bougnoux, P., and Chajes, V. 2003. Alpha-linolenic acid and cancer. In Flaxseed in human nutrition. Edited by L.U. Thompson and S.C. Cunnane. AOCS Press, Champaign, Ill., USA. pp. 233-244.
13. Bougnoux, P., Koscielny, S., Chajes, V., Descamps, P., Couet, C., and Calais, G. 1994. alpha-Linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. Br. J. Cancer, 70(2): 330-334. doi:10.1038/bjc.1994.302. PMID:7914425.
14. Bradlow, H.L., Telang, N.T., Sepkovic, D.W., and Osborne, M.P. 1996. 2-hydroxyestrone: the 'good' estrogen. J. Endocrinol. 150(Suppl.): S259-S265. doi:10.2147/IJWH.S7595. PMID:8943806.
15. Brenna, J.T., Salem, N., Jr., Sinclair, A.J., and Cunnane, S.C. 2009. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids, 80(2-3): 85-91. doi:10.1016/j.plefa.2009.01.004. PMID:19269799.
16. Brooks, J.D., and Thompson, L.U. 2005. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 94(5): 461-467. doi:10.1016/j. jsbmb.2005.02.002. PMID:15876411.
17. Brooks, J.D., Ward, W.E., Lewis, J.E., Hilditch, J., Nickell, L., Wong, E., et al. 2004. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am. J. Clin. Nutr. 79(2): 318-325. PMID:14749240.
18. Buck, K., Zaineddin, A.K., Vrieling, A., Linseisen, J., and Chang-Claude, J. 2010. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am. J. Clin. Nutr. 92(1): 141-153. doi:10.3945/ajcn.2009.28573. PMID:20463043.
19. Buck, K., Vrieling, A., Zaineddin, A.K., Becker, S., Husing, A., Kaaks, R., et al. 2011a. Serum enterolactone and prognosis of postmenopausal breast cancer. J. Clin. Oncol. 29(28): 3730-3738. doi:10.1200/JCO.2011.34.6478. PMID: 21900115.
20. Buck, K., Zaineddin, A.K., Vrieling, A., Heinz, J., Linseisen, J., Flesch-Janys, D., et al. 2011b. Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br. J. Cancer, 105(8): 1151-1157. doi:10.1038/bjc.2011.374. PMID:21915130.
21. Calder, P.C. 2012. Mechanisms of action of (n-3) fatty acids. J. Nutr. 142(3): 592S-599S. doi:10.3945/jn.111.155259. PMID:22279140.
22. Cameron, E., Bland, J., and Marcuson, R. 1989. Divergent effects of omega-6 and omega-3 fatty acids on mammary tumor development in C3H/Heston mice treated with DMBA. Nutr. Res. 9(4): 383-393. doi:10.1016/S0271-5317(89) 80115-0.
23. Canadian Cancer Society's Advisory Committee on Cancer Statistics. 2013. Canadian Cancer Statistics 2013. Toronto, Ont., Canada.
24. Carlson, R.W., Allred, D.C., Anderson, B.O., Burstein, H.J., Carter, W.B., Edge, S.B., et al. 2011. Invasive breast cancer. J. Natl. Compr. Canc. Netw. 9(2): 136-222. PMID:21310842.
25. Cheeseman, M.A. 2009. Agency response, GRAS Notice No. GRN 000280. United States Food and Drug Administration.
26. Chen, J., Stavro, P.M., and Thompson, L.U. 2002. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer, 43(2): 187-192. doi:10.1207/S15327914NC432_9. PMID:12588699.
27. Chen, J., Tan, K.P., Ward, W.E., and Thompson, L.U. 2003. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp. Biol. Med. (Maywood), 228(8): 951-958. PMID:12968067.
28. Chen, J., Hui, E., Ip, T., and Thompson, L.U. 2004. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin. Cancer Res. 10(22): 7703-7711. doi: 10.1158/1078-0432.CCR-04-1130. PMID:15570004.
29. Chen, J., Power, K.A., Mann, J., Cheng, A., and Thompson, L.U. 2007a. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr. Cancer, 58(2): 162-170. doi:10.1080/01635580701328271. PMID:17640162.
30. Chen, J., Power, K.A., Mann, J., Cheng, A., and Thompson, L.U. 2007b. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp. Biol. Med. (Maywood), 232(8): 1071-1080. doi:10.3181/0702-RM-36. PMID: 17720953.
31. Chen, J., Saggar, J.K., Corey, P., and Thompson, L.U. 2009. Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J. Nutr. 139(11): 2061-2066. doi:10. 3945/jn.109.112508. PMID:19776177.
32. Chen, J., Saggar, J.K., Corey, P., and Thompson, L.U. 2011. Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice. Br. J. Nutr. 105(3): 339-347. doi:10.1017/S0007114510003557. PMID:21138602.
33. Cognault, S., Jourdan, M.L., Germain, E., Pitavy, R., Morel, E., Durand, G., et al. 2000. Effect of an alpha-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status. Nutr. Cancer, 36(1): 33-41. PMID:10798214.
34. Dabrosin, C., Chen, J., Wang, L., and Thompson, L.U. 2002. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett. 185(1): 31-37. doi:10.1016/S0304-3835(02)00239-2. PMID:12142076.
35. Daun, J.K., Barthet, V.J., Chornick, T.L., and Duguid, S. 2003. Structure, composition, and variety development of flaxseed. In Flaxseed in Human Nutrition. Edited by L.U. Thompson and S.C. Cunnane. AOCS Press, Champaign, Ill., USA. pp. 1-40.
36. De Stefani, E., Deneo-Pellegrini, H., Mendilaharsu, M., and Ronco, A. 1998. Essential fatty acids and breast cancer: a case-control study in Uruguay. Int. J. Cancer, 76(4): 491-494. doi:10.1002/(SICI)1097-0215(19980518)76:4<491::AIDIJC8> 3.3.CO;2-I. PMID:9590123.
37. Demark-Wahnefried, W., Price, D.T., Polascik, T.J., Robertson, C.N., Anderson, E.E., Paulson, D.F., et al. 2001. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology, 58(1): 47-52. doi:10.1016/S0090-4295(01) 01014-7. PMID:11445478.
38. Dowsett, M. 2001. Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. Endocr. Relat. Cancer, 8(3): 191-195. doi:10. 1677/erc.0.0080191. PMID:11566610.
39. Evans, B.A., Griffiths, K., and Morton, M.S. 1995. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147(2): 295-302. doi:10.1677/joe.0.1470295. PMID: 7490559.
40. Fabian, C.J., Kimler, B.F., Zalles, C.M., Klemp, J.R., Petroff, B.K., Khan, Q.J., et al. 2010. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev. Res. (Phila.), 3(10): 1342-1350. doi:10.1158/1940-6207.CAPR-10-0022. PMID:2072470.
41. Frische, E.J., Hutchins, A.M., Martini, M.C., Thomas, W., and Slavin, J.L. 2003. Effect of flaxseed and wheat bran on serum hormones and lignan excretion in premenopausal women. J. Am. Coll. Nutr. 22(6): 550-554. doi:10.1080/ 07315724.2003.10719335. PMID:14684762.
42. Fritsche, K.L., and Johnston, P.V. 1990. Effect of dietary alpha-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas. J. Nutr. 120(12): 1601-1609. PMID: 1979807.
43. Gerber, M. 2012. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br. J. Nutr. 107(Suppl.2): S228-S239. doi:10.1017/ S0007114512001614. PMID:22591896.
44. Gonzalez, M.J., Schemmel, R.A., Gray, J.I., Dugan, L., Jr., Sheffield, L.G., and Welsch, C.W. 1991. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis, 12(7): 1231-1235. doi:10.1093/carcin/12.7.1231. PMID:2070488.
45. Greenlee, H., Kwan, M.L., Ergas, I.J., Sherman, K.J., Krathwohl, S.E., Bonnell, C., et al. 2009. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res. Treat. 117(3): 653-665. doi:10.1007/s10549-009-0315-3. PMID:19184414.
46. Guglielmini, P., Rubagotti, A., and Boccardo, F. 2012. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res. Treat. 132(2): 661-668. doi:10.1007/s10549-011-1881-8. PMID:22094938.
47. Gupta, M., McDougal, A., and Safe, S. 1998. Estrogenic and antiestrogenic activities of 16alpha-and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67(5-6): 413-419. doi:10.1016/S0960-0760(98)00135-6. PMID:10030690.
48. Haggans, C.J., Hutchins, A.M., Olson, B.A., Thomas, W., Martini, M.C., and Slavin, J.L. 1999. Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr. Cancer, 33(2): 188-195. doi:10.1207/ S15327914NC330211. PMID:10368815.
49. Haggans, C.J., Travelli, E.J., Thomas, W., Martini, M.C., and Slavin, J.L. 2000. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol. Biomarkers Prev. 9(7): 719-725. PMID:10919743.
50. Hall, C., III, Tulbek, M.C., and Xu, Y. 2006. Flaxseed. Adv. Food Nutr. Res. 51: 1-97. doi:10.1016/S1043-4526(06)51001-0. PMID:17011474.
51. Hassan, A., Ibrahim, A., Mbodji, K., Coeffier, M., Ziegler, F., Bounoure, F., et al. 2010. An alpha-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-kappaB in rats with TNBS-induced colitis. J. Nutr. 140(10): 1714-1721. doi:10.3945/jn.109.119768. PMID:20724486.
52. Hilakivi-Clarke, L., Cho, E., deAssis, S., Olivo, S., Ealley, E., Bouker, K.B., et al. 2001. Maternal and prepubertal diet, mammary development and breast cancer risk. J. Nutr. 131(1): 154S-157S. PMID:11208953.
53. Hutchins, A.M., Martini, M.C., Olson, B.A., Thomas, W., and Slavin, J.L. 2001. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr. Cancer, 39(1): 58-65. doi:10.1207/S15327914nc391_8. PMID:11588903.
54. Johnson, M.D., Kenney, N., Stoica, A., Hilakivi-Clarke, L., Singh, B., Chepko, G., et al. 2003. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 9(8): 1081-1084. doi:10.1038/nm902. PMID: 12858169.
55. Joint FAO/WHO Expert Committee on Food Additives. 2003. Evaluation of certain food additives and contaminants: sixty-first report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series. Geneva: 127-132.
56. Jump, D.B. 2004. Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41(1): 41-78. doi:10.1080/10408360490278341. PMID:15077723.
57. Khan, G., Penttinen, P., Cabanes, A., Foxworth, A., Chezek, A., Mastropole, K., et al. 2007. Maternal flaxseed diet during pregnancy or lactation increases female rat offspring's susceptibility to carcinogen-induced mammary tumorigenesis. Reprod. Toxicol. 23(3): 397-406. doi:10.1016/j.reprotox.2007.02.002. PMID:17398067.
58. Kolodziejczk, P.P., and Fedec, P. 1993. Processing flaxseed for human consumption. In Flaxseed in Human Nutrition. Edited by S.C. Cunnane and L.U. Thompson. AOCS Press, Champaign, Ill., USA. pp. 261-280.
59. Kuriki, K., Hirose, K., Wakai, K., Matsuo, K., Ito, H., Suzuki, T., et al. 2007. Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese. Int. J. Cancer, 121(2): 377-385. doi:10.1002/ijc.22682. PMID: 17354239.
60. Kymäläinen, H.R., and Sjöberg, A.M. 2006. Cadmium content of Finnish linseed and estimated consumer intake. Agric. Food Sci. 15: 3-11. doi:10.2137/ 145960606777245533.
61. Larsson, S.C., Kumlin, M., Ingelman-Sundberg, M., and Wolk, A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79(6): 935-945. PMID:15159222.
62. Lindahl, G., Saarinen, N., Abrahamsson, A., and Dabrosin, C. 2011. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma-and cancer cellderived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer. Cancer Res. 71(1): 51-60. doi:10.1158/0008-5472.CAN-10-2289. PMID:21097717.
63. Lowcock, E.C., Cotterchio, M., and Boucher, B.A. 2013. Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control, 24(4): 813-816. doi:10.1007/s10552-013-0155-7. PMID: 23354422.
64. Luijten, M., Singh, A.V., Bastian, C.A., Westerman, A., Pisano, M.M., Pennings, J.L., et al. 2013. Lasting effects on body weight and mammary gland gene expression in female mice upon early life exposure to n-3 but not n-6 high-fat diets. PLoS One, 8(2): e55603. doi:10.1371/journal.pone.0055603. PMID:23409006.
65. Marshall, L.A., and Johnston, P.V. 1982. Modulation of tissue prostaglandin synthesizing capacity by increased ratios of dietary alpha-linolenic acid to linoleic acid. Lipids, 17(12): 905-913. doi:10.1007/BF02534586. PMID:6298554.
66. Mason, J.K., Chen, J., and Thompson, L.U. 2010a. Flaxseed oil-trastuzumab interaction in breast cancer. Food Chem. Toxicol. 48(8-9): 2223-2226. doi:10.1016/ j.fct.2010.05.052. PMID:20580760.
67. Mason, J.K., Chen, J., and Thompson, L.U. 2010b. Flaxseed oil can increase the effectiveness of the drug trastuzumab (herceptin) in breast cancer overexpressing HER2 (BT-474). In Proceedings of the 63rd Flax Institute. Edited by J.J. Hammond. Flax Institute of the United States, Fargo, N.D., USA. pp. 10-15.
68. Mason, J.K., Fu, M.H., Chen, J., Yu, Z., and Thompson, L.U. 2013. Dietary flaxseedtrastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474). Nutr. Cancer, 65(3): 451-459. doi:10.1080/ 01635581.2013.756921. PMID:23530645.
69. McCann, S.E., Wactawski-Wende, J., Kufel, K., Olson, J., Ovando, B., Kadlubar, S.N., et al. 2007. Changes in 2-hydroxyestrone and 16alphahydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype. Cancer Epidemiol. Biomarkers Prev. 16(2): 256-262. doi:10.1158/1055-9965.EPI-06-0633. PMID:17301257.
70. McCann, S.E., Thompson, L.U., Nie, J., Dorn, J., Trevisan, M., Shields, P.G., et al. 2010. Dietary lignan intakes in relation to survival among women with breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res. Treat. 122(1): 229-235. doi:10.1007/s10549-009-0681-x. PMID:20033482.
71. Menendez, J.A., Vazquez-Martin, A., Ropero, S., Colomer, R., and Lupu, R. 2006. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the "fat features" of the "Mediterranean diet" as an "anti-HER2 cocktail". Clin. Transl. Oncol. 8(11): 812-820. doi:10.1007/s12094-006-0137-2. PMID:17134970.
72. Nkondjock, A., Shatenstein, B., and Ghadirian, P. 2003. A case-control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada. Breast, 12(2): 128-135. doi:10.1016/S0960-9776(02)00284-9. PMID:14659342.
73. Olsen, A., Christensen, J., Knudsen, K.E., Johnsen, N.F., Overvad, K., and Tjonneland, A. 2011. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer. Breast Cancer Res. Treat. 128(3): 883-889. doi:10.1007/s10549-011-1397-2. PMID:21340481.
74. Osborne, M.P., Bradlow, H.L., Wong, G.Y., and Telang, N.T. 1993. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Inst. 85(23): 1917-1920. doi:10. 1093/jnci/85.23.1917. PMID:8230281.
75. Patterson, R.E. 2011. Flaxseed and breast cancer: what should we tell our patients? J. Clin. Oncol. 29(28): 3723-3724. doi:10.1200/JCO.2011.37.9669. PMID: 21900107.
76. Penttinen, P., Jaehrling, J., Damdimopoulos, A.E., Inzunza, J., Lemmen, J.G., van der Saag, P., et al. 2007. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology, 148(10): 4875-4886. doi:10.1210/en.2007-0289. PMID:17628008.
77. Pitot, H.C. 1993. The molecular biology of carcinogenesis. Cancer, 72(3 Suppl.): 962-970. doi:10.1002/1097-0142(19930801)72:3+<962::AID-CNCR2820721303> 3.0.CO;2-H. PMID:8334671.
78. Power, K.A., Chen, J.M., Saarinen, N.M., and Thompson, L.U. 2008. Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short-and long-term treatment with soy and flaxseed. J. Steroid Biochem. Mol. Biol. 112(1-3): 13-19. doi:10.1016/j.jsbmb.2008.07.003. PMID:18703142.
79. Rao, G.N., Ney, E., and Herbert, R.A. 2000. Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Res. Treat. 64(3): 287-296. doi:10.1023/A:1026552405042. PMID: 11200779.
80. Ratnayake, W.M.N., Behrens, W.A., Fischer, P.W.F., L'Abbé, M.R., Mongeau, R., and Beare-Rogers, J.L. 1992. Chemical and nutritional studies of flaxseed (variety Linott) in rats. J. Nutr. Biochem. 3(5): 232-240. doi:10.1016/0955-2863(92)90045-K.
81. Rausch, S.M., Winegardner, F., Kruk, K.M., Phatak, V., Wahner-Roedler, D.L., Bauer, B., et al. 2011. Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer, 19(4): 521-529. doi:10.1007/s00520-010-0846-5. PMID:20336329.
82. Rickard, S.E., Yuan, Y.V., Chen, J., and Thompson, L.U. 1999. Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr. Cancer, 35(1): 50-57. doi:10.1207/S1532791450-57. PMID: 10624706.
83. Russo, J., and Russo, I.H. 2004. Development of the human breast. Maturitas, 49(1): 2-15. doi:10.1016/j.maturitas.2004.04.011. PMID:15351091.
84. Russo, J., Tay, L.K., and Russo, I.H. 1982. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 2(1): 5-73. doi: 10.1007/BF01805718. PMID:6216933.
85. Russo, J., Hu, Y.F., Yang, X., and Russo, I.H. 2000. Developmental, cellular, and molecular basis of human breast cancer. J. Natl. Cancer Inst. Monogr. 2000(27): 17-37. doi:10.1093/oxfordjournals.jncimonographs.a024241. PMID: 10963618.
86. Saadatian-Elahi, M., Norat, T., Goudable, J., and Riboli, E. 2004. Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int. J. Cancer, 111(4): 584-591. doi:10.1002/ijc.20284. PMID:15239137.
87. Saarinen, N.M., Huovinen, R., Warri, A., Makela, S.I., Valentin-Blasini, L., Sjoholm, R., et al. 2002. Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol. Cancer Ther. 1(10): 869-876. PMID:12492120.
88. Saarinen, N.M., Power, K., Chen, J., and Thompson, L.U. 2006. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int. J. Cancer, 119(4): 925-931. doi:10.1002/ijc.21898. PMID:16557589.
89. Saarinen, N.M., Power, K.A., Chen, J., and Thompson, L.U. 2008. Lignans are accessible to human breast cancer xenografts in athymic mice. Nutr. Cancer, 60(2): 245-250. doi:10.1080/01635580701649669. PMID:18444157.
90. Saarinen, N.M., Abrahamsson, A., and Dabrosin, C. 2010a. Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo. Int. J. Cancer, 127(3): 737-745. doi:10.1002/ijc.25052. PMID:19924815.
91. Saarinen, N.M., Smeds, A.I., Penalvo, J.L., Nurmi, T., Adlercreutz, H., and Makela, S. 2010b. Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum. J. Nutr. Metab. 2010. doi:10.1155/2010/403076. PMID: 20721350.
92. Saggar, J.K., Chen, J., Corey, P., and Thompson, L.U. 2010a. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor-and growth factor-signaling pathways. Mol. Nutr. Food Res. 54(3): 415-425. doi:10.1002/mnfr.200900068. PMID: 19904759.
93. Saggar, J.K., Chen, J., Corey, P., and Thompson, L.U. 2010b. The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutr. Cancer, 62(4): 533-542. doi:10.1080/01635580903532440. PMID:20432175.
94. Sala-Vila, A., and Calder, P.C. 2011. Update on the relationship of fish intake with prostate, breast, and colorectal cancers. Crit. Rev. Food Sci. Nutr. 51(9): 855-871. doi:10.1080/10408398.2010.483527. PMID:21888535.
95. Schley, P.D., Brindley, D.N., and Field, C.J. 2007. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J. Nutr. 137(3): 548-553. PMID:17311938.
96. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K.E., Bradlow, H.L., et al. 1982. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. U.S.A. 79(9): 3047-3051. doi:10.1073/pnas. 79.9.3047. PMID:6953448.
97. Serraino, M., and Thompson, L.U. 1991. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett. 60(2): 135-142. doi:10.1016/0304-3835(91)90220-C. PMID:1657368.
98. Serraino, M., and Thompson, L.U. 1992. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr. Cancer, 17(2): 153-159. doi:10.1080/01635589209514182. PMID:1584708.
99. Shannon, J., King, I.B., Moshofsky, R., Lampe, J.W., Gao, D.L., Ray, R.M., et al. 2007. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am. J. Clin. Nutr. 85(4): 1090-1097. PMID:17413110.
100. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J.S., Nobel, A., et al. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U.S.A. 100(14): 8418-8423. doi:10.1073/ pnas.0932692100. PMID:12829800.
101. Sturgeon, S.R., Heersink, J.L., Volpe, S.L., Bertone-Johnson, E.R., Puleo, E., Stanczyk, F.Z., et al. 2008. Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women. Nutr. Cancer, 60(5): 612-618. doi:10.1080/01635580801971864. PMID:18791924.
102. Sturgeon, S.R., Volpe, S.L., Puleo, E., Bertone-Johnson, E.R., Heersink, J., Sabelawski, S., et al. 2010. Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women. Nutr. Cancer, 62(2): 175-180. doi:10.1080/01635580903305342. PMID:20099191.
103. Tan, K.P., Chen, J., Ward, W.E., and Thompson, L.U. 2004. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp. Biol. Med. (Maywood), 229(2): 147-157. PMID: 14734793.
104. Theriault, R.L., Carlson, R.W., Allred, C., Anderson, B.O., Burstein, H.J., Edge, S.B., et al. 2013. Breast Cancer, Version 3.2013. J. Natl. Compr. Canc. Netw. 11(7): 753-761. PMID:23847214.
105. Thiebaut, A.C., Chajes, V., Gerber, M., Boutron-Ruault, M.C., Joulin, V., Lenoir, G., et al. 2009. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int. J. Cancer, 124(4): 924-931. doi:10.1002/ijc.23980. PMID:19035453.
106. Thompson, L.U. 2003. Analysis and bioavailability of lignans. In Flaxseed in Human Nutrition. Edited by L.U. Thompson and S.C. Cunnane. AOCS Press, Champaign, Ill., USA. pp. 92-116.
107. Thompson, L.U., Rickard, S.E., Orcheson, L.J., and Seidl, M.M. 1996a. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis, 17(6): 1373-1376. doi:10.1093/carcin/17.6. 1373. PMID:8681458.
108. Thompson, L.U., Seidl, M.M., Rickard, S.E., Orcheson, L.J., and Fong, H.H. 1996b. Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr. Cancer, 26(2): 159-165. doi:10.1080/01635589609514472. PMID:8875553.
109. Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K., and Goss, P.E. 2005. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 11(10): 3828-3835. doi:10.1158/1078-0432.CCR-04-2326. PMID:15897583.
110. Thompson, L.U., Boucher, B.A., Liu, Z., Cotterchio, M., and Kreiger, N. 2006. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr. Cancer, 54(2): 184-201. doi:10.1207/ s15327914nc5402_5. PMID:16898863.
111. Thompson, L.U., Truan, J., and Chen, J. 2010. Flaxseed oil is more effective than lignan in reducing the growth of estrogen sensitive human breast cancer (MCF-7) at high circulating estrogen level. In Proceedings of the 63rd Meeting of the Flax Institute of the United States, Doublewood Inn, Fargo, North Dakota, 25-26 March 2010. Flax Institute of the United States.
112. Tou, J.C., and Thompson, L.U. 1999. Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis, 20(9): 1831-1835. doi:10.1093/carcin/20.9.1831. PMID: 10469631.
113. Truan, J.S., Chen, J.M., and Thompson, L.U. 2010. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Mol. Nutr. Food Res. 54(10): 1414-1421. doi:10.1002/mnfr.200900521. PMID:20425756.
114. Truan, J.S., Chen, J.M., and Thompson, L.U. 2012. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice. Nutr. Cancer, 64(1): 65-71. doi:10.1080/01635581.2012.630165. PMID:22136581.
115. Velentzis, L.S., Cantwell, M.M., Cardwell, C., Keshtgar, M.R., Leathem, A.J., and Woodside, J.V. 2009. Lignans and breast cancer risk in pre-and postmenopausal women: meta-analyses of observational studies. Br. J. Cancer, 100(9): 1492-1498. doi:10.1038/sj.bjc.6605003. PMID:19337250.
116. Wang, D., and Dubois, R.N. 2010. Eicosanoids and cancer. Nat. Rev. Cancer, 10(3): 181-193. doi:10.1038/nrc2809. PMID:20168319.
117. Wang, C., Makela, T., Hase, T., Adlercreutz, H., and Kurzer, M.S. 1994. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Mol. Biol. 50(3-4): 205-212. doi:10.1016/0960-0760(94) 90030-2. PMID:8049151.
118. Ward, W.E., Jiang, F.O., and Thompson, L.U. 2000. Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr. Cancer, 37(2): 187-192. doi:10.1207/S15327914NC372_11. PMID:11142092.
119. Welsh, J. 2007. Steroid hormones and their receptors in breast cancer. In The World of Hormones: Molecular and Physiological Insights. Edited by H. Henry and A. Norman. Henry Stewart Talks Ltd., London, UK.
120. Wiggins, A.K., Mason, J.K., and Thompson, L.U. 2013. Beneficial influence of diets enriched with flaxseed and flaxseed oil on cancer. In Cancer Chemoprevention and Treatment by Diet Therapy. Edited by W.C.S. Cho. Springer Science + Business Media Dordrecht, Dordrecht, the Netherlands. pp. 55-90.
121. World Cancer Research Fund/American Institute for Cancer Research 2007. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC, USA.
122. Yang, X.R., Sherman, M.E., Rimm, D.L., Lissowska, J., Brinton, L.A., Peplonska, B., et al. 2007. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol. Biomarkers Prev. 16(3): 439-443. doi:10.1158/1055-9965.EPI-06-0806. PMID:17372238.
123. Yu, B., Khan, G., Foxworth, A., Huang, K., and Hilakivi-Clarke, L. 2006. Maternal dietary exposure to fiber during pregnancy and mammary tumorigenesis among rat offspring. Int. J. Cancer, 119(10): 2279-2286. doi:10.1002/ijc.22201. PMID:16921499.
124. Zaineddin, A.K., Vrieling, A., Buck, K., Becker, S., Linseisen, J., Flesch-Janys, D., et al. 2012. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int. J. Cancer, 130(6): 1401-1410. doi:10.1002/ijc.26157. PMID:21544804.
125. Zheng, J.S., Hu, X.J., Zhao, Y.M., Yang, J., and Li, D. 2013. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ, 346: 3706. doi:10. 1136/bmj.f3706. PMID:23814120.